SHANGHAI LABWAY CLINICAL LABORATORY CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.16 CNY | -0.37% |
|
+0.49% | -38.60% |
| Jul. 02 | Tranche Update on Shanghai Labway Clinical Laboratory Co., Ltd's Equity Buyback Plan announced on November 16, 2023. | CI |
| May. 30 | Labway Clinical Laboratory Names Chief Financial Officer | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Medical & Diagnostic Laboratories
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 451M | - | - | - | - | - | |
| 8.4B | ||||||
| 4.42B | - | - | ||||
| 2.94B | ||||||
| 2.65B | ||||||
| 1.83B | - |
